In summary, we delineate a novel pathway in which dietary glutamine stabilizes GLS1, enabling its nuclear interaction with POLR2H/POLR2E to suppress RNA pol II activity and attenuate alcohol‐induced hepatic steatosis. Here, GLS is linked to fatty liver disease.